Analyst who called Lehman Bros. collapse issues new warning involving these 45 firms in more than a dozen industries. More here...Analyst who called lehman bros. Collapse issues new warning involving these 45 firms in more than a dozen industries. More here....
The company posted this strange legal promise to early investors on their website and what it says is truly shocking if you read between the lines. I've been investigating this situation very closely and have uncovered a "ChatGPT loophole" that may have just changed everything. See what I've found
PIERRE, S.D. (AP) — South Dakota Republican Gov. Kristi Noem has requested guidance from the state’s Supreme Court about conflict-of-interest rules for lawmakers, several weeks after a South Dakota state lawmaker that she received for her day care business. Continue Reading ➔
NEW YORK (AP) — Foiled in their longshot bid for an early verdict, lawyers will start calling witnesses of their own Monday in the New York civil fraud trial that threatens the former president’s real estate empire. Continue Reading ➔
Since 2005, Amazon's "royalties" have gone on a tear... But most of the population has never heard of this... And that's why Brad Thomas decided to take charge and ensure the masses -- including yourself -- have access to this strategy... How to get started
Kai-Fu Lee's AI startup 01.AI has joined the unicorn club by outshining Meta's Llama 2 with its new open-source AI model, highlighting its rapid valuation growth and global technological impact in AI development. Continue Reading ➔
With the festive season on the horizon, consumers are grappling with the dual realities of persistently high prices and the allure of increased savings. Continue Reading ➔
Reuters calls it a "modern-day gold rush for drug makers". But how much money can this medical breakthrough make? Barclays Bank predicts it will grow into a $200 billion market. Making the upside potential of one drug maker as high as 42,000%. See the proof here
A recent survey revealed that over 80% of American voters fear the U.S. could be dragged into the ongoing conflict between Israel and Hamas. Continue Reading ➔
SciSparc Ltd. (NASDAQ: SPRC), a clinical-stage pharmaceutical company, reported a new Phase IIb trial of SCI-110, a proprietary THC-based medication for Tourette Syndrome (TS) treatment. Continue Reading ➔
Marc Chaikin's stock-picking system isolated Nvidia before its massive bull run this year. Now, it just flashed "BUY" on a new AI company that no one is talking about yet. It's not a household name... but Marc predicts it could quickly double or triple from here. See the name and ticker
U.S. regulators say they will review the use of a chemical found in almost every tire after a petition from West Coast Native American tribes that want it banned because it kills salmon as they return from the ocean to their natal streams to spawn. Continue Reading ➔
In the ever-evolving realm of cannabis entrepreneurship, few have left as indelible a mark as Berner, known to many as Gilbert Anthony Milam, Jr. His journey through this dynamic industry, marked by innovation and success, is nonetheless marred by a series of controversies that have raised profound questions a Continue Reading ➔
CHEYENNE, Wyo. (AP) — A federal lawsuit filed Tuesday alleges The Church of Jesus Christ of Latter-day Saints investment arm misused hundreds of thousands of dollars donated by three men by investing the money instead of using it for as they claim was promised. Continue Reading ➔
Smart investors are always trying to get the best possible deal on whatever security or asset they are buying. The better the deal, the higher the chance of generating a substantial ROI. To do so, we use a wide array of tools to try and analyze today's top undervalued stocks. Within this report you'll find 4 stocks selling below intrinsic value with growth potential.
House Republicans proposed reducing Transportation Secretary Pete Buttigieg's salary to a mere $1 amid intense debates over spending bills. Continue Reading ➔
Information, charts or examples contained in this email are for illustration and educational purposes only and not for individualized investment management. This message contains commercial elements, such as advertising as well as partner offers for which we may receive affiliate compensation. We only send these offers to those who have opted in to our newsletter. If you wish to no longer receive these offers click on the unsubscribe link at the bottom of this email. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained in this email or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.
Post a Comment
Post a Comment